SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.026
AS - Asia 3.950
EU - Europa 2.888
SA - Sud America 596
AF - Africa 61
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.858
SG - Singapore 1.610
CN - Cina 1.242
DE - Germania 821
UA - Ucraina 511
BR - Brasile 497
GB - Regno Unito 349
IT - Italia 338
HK - Hong Kong 332
FI - Finlandia 330
TR - Turchia 315
VN - Vietnam 207
RU - Federazione Russa 132
SE - Svezia 109
CA - Canada 92
FR - Francia 67
IN - India 65
MX - Messico 58
PL - Polonia 57
JP - Giappone 40
BE - Belgio 38
AR - Argentina 31
BD - Bangladesh 31
NL - Olanda 31
ZA - Sudafrica 30
ES - Italia 28
LT - Lituania 26
EC - Ecuador 18
ID - Indonesia 18
IQ - Iraq 16
CZ - Repubblica Ceca 15
CO - Colombia 12
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
PK - Pakistan 9
MA - Marocco 8
PY - Paraguay 8
TN - Tunisia 8
VE - Venezuela 8
CL - Cile 7
IR - Iran 7
UY - Uruguay 7
AT - Austria 6
IL - Israele 6
NP - Nepal 6
PE - Perù 6
DO - Repubblica Dominicana 5
BG - Bulgaria 4
GR - Grecia 4
IE - Irlanda 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
EG - Egitto 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
NO - Norvegia 3
SN - Senegal 3
AL - Albania 2
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
KR - Corea 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
SV - El Salvador 2
AM - Armenia 1
AZ - Azerbaigian 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
NE - Niger 1
NI - Nicaragua 1
TT - Trinidad e Tobago 1
Totale 17.528
Salva come PNG Salva come JPEG
Città #
Fairfield 1.156
Woodbridge 1.108
Ashburn 1.020
Singapore 964
Houston 666
Jacksonville 576
Ann Arbor 564
Chandler 513
Seattle 442
Beijing 424
Wilmington 411
Santa Clara 402
Cambridge 379
Munich 340
Hong Kong 330
Izmir 185
Nanjing 154
Los Angeles 153
Helsinki 145
New York 143
Dallas 129
Milan 118
Princeton 113
San Diego 101
Boardman 100
Shanghai 88
Turku 72
Ho Chi Minh City 68
São Paulo 64
Ferrara 61
Nanchang 60
Dearborn 54
Shenyang 47
Warsaw 47
Hanoi 46
London 45
Tokyo 39
Brussels 37
Mexico City 37
Frankfurt am Main 35
Hebei 35
Bremen 34
Falkenstein 33
Brooklyn 30
Buffalo 29
Hefei 29
Tianjin 29
Auburn Hills 25
Denver 25
Chicago 24
Jiaxing 24
Mountain View 24
Orem 24
San Mateo 24
Atlanta 22
Falls Church 22
Johannesburg 22
Mcallen 22
Toronto 22
Montreal 21
Norwalk 21
Rio de Janeiro 20
Changsha 19
Bologna 17
Jinan 17
Montréal 17
Moscow 17
Philadelphia 17
Stockholm 17
Zhengzhou 17
Addison 16
Boston 16
Chennai 16
Phoenix 16
San Francisco 16
Mumbai 15
Redwood City 15
The Dalles 15
Kunming 14
Manchester 14
Poplar 14
Tappahannock 13
Indiana 12
Belo Horizonte 11
Ningbo 10
Washington 10
Bexley 9
Biên Hòa 9
Charlotte 9
Columbus 9
Dhaka 9
Guangzhou 9
Olomouc 9
Tashkent 9
Wroclaw 9
Ankara 8
Guayaquil 8
Orange 8
Padova 8
Verona 8
Totale 12.479
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 341
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 274
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 246
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 238
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 233
A new selective antagonist of the nociceptin receptor 232
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 220
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 217
A new ligand for the urotensin II receptor 216
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 214
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 212
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 209
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 208
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 203
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 201
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 201
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 192
Effects of vasoactive agents in healthy and diseased human saphenous veins 191
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 189
Ala scan analogues of HOE 140. Synthesis and biological activities 189
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 188
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 185
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 185
Pharmacological characterization of tachykinin tetrabranched derivatives 185
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 184
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 184
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 183
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 183
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 181
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 180
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 179
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 177
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 176
Pharmacological characterization of nociceptin receptor: an in vitro study 176
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 175
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 175
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 172
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 172
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 171
Pharmacological characterisation of novel kinin B2 receptor ligands 170
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 170
B1 and B2 kinin receptors in various species 169
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 168
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 168
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 167
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 166
Structure-activity study at positions 3 and 4 of human neuropeptide S. 164
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 164
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 164
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 163
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 163
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 162
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 162
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 161
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 155
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 155
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 154
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 154
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 153
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 151
Characterization of the human vascular kinin B2 receptor by binding assays. 151
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 150
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 148
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 146
Structure-activity relationship study on human urotensin II 146
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 145
Characterization of endothelin receptors in the human umbilical artery and vein 145
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 145
Nociceptin/orphanin FQ receptor ligands 143
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 142
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 141
Pharmacology of the Kallikrein-Kinin system 141
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 140
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 139
Receptors for kinins in the human isolated umbilical vein 137
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 136
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 136
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 136
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 135
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 134
Pharmacology of nociceptin and its receptor: a novel therapeutic target 133
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 131
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 130
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 128
Endogenous nociceptin signaling and stress-induced analgesia 128
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 128
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 125
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 125
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 123
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 121
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 118
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 117
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 114
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 114
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 111
null 110
null 105
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 103
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 103
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 94
Totale 16.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021842 0 0 0 0 0 160 46 178 31 171 188 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.838 67 70 209 108 326 315 126 171 418 239 430 359
2025/20264.041 849 329 619 1.013 1.132 99 0 0 0 0 0 0
Totale 17.628